Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: A cross sectional study
BMC Pulmonary Medicine May 13, 2018
Musarurwa C, et al. - Researchers determined the prevalence, covariates of vitamin D deficiency (VDD) and risk of pulmonary tuberculosis (PTB) among human immunodeficiency virus (HIV)- infected hospitalized patients with and without PTB. Among hospitalised HIV-infected patients in the present study, a link was observed between higher serum 25-hydroxyvitamin D [25(OH) D] concentrations and active PTB and tuberculosis (TB)-related mortality. This finding is at variance with the commonly reported relation of hypovitaminosis and susceptibility to TB.
Methods
- This comparative cross-sectional study included 145 HIV+/pulmonary TB+ (PTB) and 139 HIV+/PTB- hospitalised patients.
- From participants enrolled in a randomised controlled trial (RCT) conducted to investigate the impact of using a point-of-care urine lipoarabinomannan strip test for TB diagnosis, archived serum specimens were selected using stratified random sampling.
- Sputum smear microscopy, culture or GeneXpert MTB/RIF were used to corroborate PTB status.
- Prior to commencement of anti-TB treatment, competitive chemiluminescent immunoassay was used to assay serum 25-hydroxyvitamin D [25(OH) D] concentrations.
- Researchers determined the impact of VD status on duration of hospital stay and patient outcomes on follow up at 8 weeks.
- Using Mann-Whitney test, median serum 25(OH) D concentrations were compared.
- They assessed covariates of serum VD status using logistic regression analysis.
Results
- The reported overall VDD prevalence in the cohort was 40.9% (95% CI: 35.1–46.8).
- Significantly higher median serum 25(OH)D concentrations were detected in HIV+/PTB+ group (25.3 ng/ml, IQR:18.0–33.7) vs the HIV+/PTB- group (20.4 ng/ml, IQR:14.6–26.9), p=0.0003.
- Relative to those with serum 25(OH) D concentrations 30 ng/ml, patients with serum 25(OH) D concentration?≥?30 ng/ml were found to be 1.9 times more likely to be PTB+ (odds ratio (OR) 1.91; 95% CI 1.1–3.2).
- PTB-related death was found to be related to higher odds of having 25(OH) D levels≥30 ng/ml.
- No association of age, gender, CD4+ count, combination antiretroviral therapy (cART) status, efavirenz based cART regimen and length of hospital stay with vitamin D status was found.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries